Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: WebinarsShorts
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Dr. Gino K. In

Advertisement

Articles by Dr. Gino K. In

Image of Day and In

Jim Day Was Given 6 Months to Live. Then He Tried a Cancer-Fighting Virus

ByDr. Gino K. In,Jim Day
August 28th 2026

Jim Day was told he had six months to live after a stage 4 melanoma diagnosis. A cancer-fighting virus helped shrink his tumors and gave him hope.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on CURE

    1

    Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic Cancer

    2

    FDA Approves Rasonque, First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer

    3

    Prostate Cancer Patients Got the Same Result in Fewer Visits

    4

    Chemoradiotherapy Preserves the Rectum in 78.5% of Patients at 1 Year

    5

    Dolly Parton, 80, Dies Following a Brief Battle with Cancer

    • About Us
    • Advertise / Support
    • Editorial Board
    • Contact Us
    • CancerNetwork.com
    • TargetedOnc.com
    • OncLive.com
    • OncNursingNews.com
    • Terms & Conditions
    • Privacy
    • Do Not Sell My Information
    • Washington My Health My Data
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.